<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04619160</url>
  </required_header>
  <id_info>
    <org_study_id>MMS.2019.043</org_study_id>
    <nct_id>NCT04619160</nct_id>
  </id_info>
  <brief_title>Propofol Versus Sevoflurane During FESS</brief_title>
  <official_title>Influence of Propofol Versus Sevoflurane on Surgical Conditions During Functional Endoscopic Sinus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Algemeen Ziekenhuis Maria Middelares</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Algemeen Ziekenhuis Maria Middelares</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Good surgical conditions are crucial for an optimal surgery result and safe procedure.&#xD;
      Minimal blood loss in the surgical field is one of the most important conditions to maintain&#xD;
      a good visualization, especially in surgeries with a small surgical field such as a FESS&#xD;
      (functional endoscopic sinus surgery). The perioperative blood loss is determined by the main&#xD;
      arterial and venous pressure, the local pressure and the capillary vascular filling pressure.&#xD;
&#xD;
      It has been proposed that propofol is a venodilator, which increases the blood flow, but&#xD;
      decreases the capillary pressure. On the contrary, sevoflurane might act mainly on the&#xD;
      arterioles, which causes an increase in the capillary pressure. In a previous study it has&#xD;
      been demonstrated that despite blood pressure maintenance, propofol causes less bleeding&#xD;
      during spinal surgery than sevoflurane.&#xD;
&#xD;
      The main aim of this study was to compare both anaesthetics on the perioperative bleeding and&#xD;
      haemodynamics during FESS. Secondary, the postoperative nausea, vomiting, pain scores,&#xD;
      surgery duration and length of stay at the post-anesthesia care unit will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      2 X 30 patients which are planned for FESS surgery are randomized in a sevoflurane group or&#xD;
      propofol group.&#xD;
&#xD;
      All patients will be induced with propofol (target-controlled infusion (TCI) 4 µg/mL) and&#xD;
      remifentanil (TCI 4 ng/mL) and receive a multimodal intravenous analgesia.&#xD;
&#xD;
      Patients in the propofol group will receive further intravenous propofol until a bispectral&#xD;
      index (BIS) value of 50 is reached.&#xD;
&#xD;
      The intravenous drip of propofol will be stopped after induction in the sevoflurane group and&#xD;
      patients will receive sevoflurane as inhalation anaesthetic (1 MAC) until a BIS-value of 50.&#xD;
      The surgeon will be blinded for patient allocation.&#xD;
&#xD;
      The surgical conditions will be graded postoperatively by the surgeon who performed the&#xD;
      operation using the validated Boezaart grading scale. The endoscopic images will be evaluated&#xD;
      in addition by 3 blinded surgeons using this same scale.&#xD;
&#xD;
      Besides the surgical conditions, haemodynamic parameters, nausea and vomiting scores (PONV),&#xD;
      Visual Analogue Score (VAS), surgery duration, length of stay at the post-anesthesia care&#xD;
      unit and postoperative analgesia and anti-emetics are registered.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>The surgeon and participant are blinded for randomization. The anesthesiologist is unblinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Boezaart surgical grading scale</measure>
    <time_frame>during surgery</time_frame>
    <description>Evaluation of surgical conditions by determination of the validated Boezaart surgical grading scale. Score 0 (no bleeding) to 5 (severe bleeding) The scale will be determined by the operating surgeon and 3 independent surgeons based on an endoscopic video recording.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgery duration</measure>
    <time_frame>Immediately after surgery</time_frame>
    <description>Length of surgery in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood pressure</measure>
    <time_frame>During surgery</time_frame>
    <description>Mean Arterial Blood Pressure (in mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay on the PACU</measure>
    <time_frame>From arrival on the PACU until achievement of the PACU discharge criteria</time_frame>
    <description>number of minutes on the PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain scores</measure>
    <time_frame>in the first 48 hours after surgery</time_frame>
    <description>Postoperative Visual Analogue scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PONV scores</measure>
    <time_frame>In the first 48 hours after surgery</time_frame>
    <description>Postoperative nausea/vomiting scores</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sinus Infection Chronic</condition>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>TCI 4 µg/mL start until BIS-value of 50</description>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>start 1 MAC, until BIS-value of 50</description>
    <arm_group_label>sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient planned for FESS surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients which receive anticoagulants&#xD;
&#xD;
          -  patients which have coagulation disorders&#xD;
&#xD;
          -  patients with high bleeding risk&#xD;
&#xD;
          -  patients with arterial hypertension&#xD;
&#xD;
          -  other decided by surgeon&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain F Kalmar, MD, PhD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maria Middelares Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alain F Kalmar, MD, PhD, MSc</last_name>
    <phone>+32 246 17 29</phone>
    <email>alainkalmar@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicky Van Der Vekens, DVM, PhD</last_name>
    <phone>+32 246 1709</phone>
    <email>nicky.vandervekens@azmmsj.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>General Hospital Maria Middelares</name>
      <address>
        <city>Ghent</city>
        <state>Oost-Vlaanderen</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain F Kalmar, MD, PhD</last_name>
      <phone>+32 9 246 1729</phone>
      <email>alainkalmar@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 28, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2020</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Algemeen Ziekenhuis Maria Middelares</investigator_affiliation>
    <investigator_full_name>Dr. Alain Kalmar, MD, PhD</investigator_full_name>
    <investigator_title>Staff Anesthesist</investigator_title>
  </responsible_party>
  <keyword>haemodynamic</keyword>
  <keyword>peripheral blood flow</keyword>
  <keyword>FESS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

